Ramsay Health Care Limited
RMSYF · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 13.08B | 9.97B | 1.39B | 274.00M | 1.10 |
| 2023 FY | 14.96B | 11.52B | 1.64B | 298.10M | 1.16 |
| 2024 FY | 16.56B | 12.85B | 833.20M | 888.70M | 1.11 |
| 2025 FY | 17.67B | 13.67B | 870.50M | 24.00M | 0.03 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 19.47B | 14.95B | 314.20M | 10.70B | 3.93B |
| 2023 FY | 21.03B | 16.21B | 656.10M | 11.89B | 4.15B |
| 2024 FY | 20.89B | 15.37B | 662.30M | 10.94B | 4.90B |
| 2025 FY | 22.48B | 16.77B | 784.40M | 12.12B | 5.02B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 715.50M | -708.50M | 7.00M | -351.90M | -690.60M |
| 2023 FY | 1.28B | -720.90M | 558.70M | -218.70M | 341.90M |
| 2024 FY | 1.29B | -753.80M | 539.00M | -158.30M | 6.20M |
| 2025 FY | 1.48B | -776.60M | 704.20M | -190.70M | 746.60M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 16.87B | 27.25B | — | — | — |
| 2023 FY | 12.55B | 23.78B | — | — | — |
| 2024 FY | 11.80B | 22.07B | — | — | — |
| 2025 FY | 30.98B | 42.31B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2024 Q4 | 8.58B | 1.04B | 1.04B | 130.20M | 0.49 |
| 2025 Q2 | 8.54B | 1.02B | 1.02B | -104.90M | -0.50 |
| 2025 Q4 | 9.25B | 1.10B | 1.10B | 128.90M | 0.52 |
| 2026 Q2 | 9.34B | 864.76M | 484.51M | 160.64M | 0.66 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2024 Q4 | 20.89B | 15.37B | 662.30M | 10.94B | 4.90B |
| 2025 Q2 | 20.66B | 15.22B | 342.70M | 11.28B | 4.81B |
| 2025 Q4 | 22.48B | 16.77B | 784.40M | 12.12B | 5.02B |
| 2026 Q2 | 21.69B | 15.97B | 468.82M | 17.53B | 5.04B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2024 Q4 | 1.08B | -353.20M | 731.50M | -82.80M | 300.60M |
| 2025 Q2 | 299.60M | -375.80M | -76.20M | -80.60M | 341.10M |
| 2025 Q4 | 1.18B | -400.80M | 780.40M | -81.00M | -341.10M |
| 2026 Q2 | 356.66M | -417.94M | -61.28M | -100.06M | -303.91M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2024 Q4 | 12.66B | 22.94B | — | — | — |
| 2025 Q2 | 7.21B | 18.15B | — | — | — |
| 2025 Q4 | 9.42B | 20.75B | — | — | — |
| 2026 Q2 | 6.89B | 23.95B | — | — | — |